23 February 2023

Safety alerts regarding pharmaceutical products and medical devices

Reference: CIR-2023-00000021

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

 

 

Lifting the Suspension on the Registration of the Medical Product Proton 40MG E.C Tab and Proton 20MG E.C Tab

Field Safety Notice ORISE™ Gel Submucosal Lifting Agent

Recall of Pharmaceutical Product Finallerg 1mg/1ml

 

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Proton 40 MG E.C Tab - Proton 20 MG E.C Tab - رفع التعليق عن تسجيل منتج ==.pdf:

View Document

تقارير السلامة للوسائل الطبية - ORISE Gel Submucosal Lifting Agent --.pdf:

View Document

سحب المنتج الطبي -Finallerg 1mg- 1ml ---.pdf:

View Document